-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Natural Killer Cells: A New Frontier for Cancer Immunotherapy (ticketed session for in-person participants)

PhD Trainee  Ticketed Session
Program: Meet the Scientist
Sunday, December 10, 2023: 8:00 AM-9:00 AM
Aqua 300 (Hilton San Diego Bayfront)
Katy Rezvani, MD, The University of Texas M D Anderson Cancer Center
Rezvani: Takeda: Patents & Royalties; Affimed: Other: License agreement.
See more of: Meet the Scientist